Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Aquisol** is a topical antiseptic hand-rub and skin-disinfection solution marketed by Arges Life Science. It is a fixed-dose preparation containing chlorhexidine gluconate 0.5% w/v and isopropyl alcohol 70% v/v, intended for disinfection of clean intact skin, surgical hand antisepsis, pre-procedural skin preparation, and disinfection associated with wound dressing and surgical instruments. Chlorhexidine is a cationic biguanide antiseptic that binds negatively charged microbial cell surfaces and disrupts membrane integrity; isopropyl alcohol provides rapid topical antiseptic activity. ([argeslife.com](https://www.argeslife.com/insert/aqusol.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aquisol.